These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 12544376)
1. Anticipatory anxiety in moderately to highly-anxious oral surgery patients as a screening model for anxiolytics: evaluation of alprazolam. Wolf DL; Desjardins PJ; Black PM; Francom SR; Mohanlal RW; Fleishaker JC J Clin Psychopharmacol; 2003 Feb; 23(1):51-7. PubMed ID: 12544376 [TBL] [Abstract][Full Text] [Related]
2. Amnestic and anxiolytic effects of alprazolam in oral surgery patients. Coldwell SE; Milgrom P; Getz T; Ramsay DS J Oral Maxillofac Surg; 1997 Oct; 55(10):1061-70. PubMed ID: 9331228 [TBL] [Abstract][Full Text] [Related]
3. The acute effects of L-theanine in comparison with alprazolam on anticipatory anxiety in humans. Lu K; Gray MA; Oliver C; Liley DT; Harrison BJ; Bartholomeusz CF; Phan KL; Nathan PJ Hum Psychopharmacol; 2004 Oct; 19(7):457-65. PubMed ID: 15378679 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic and -dynamic studies with a new anxiolytic, suriclone, utilizing EEG mapping and psychometry. Saletu B; Grünberger J; Linzmayer L; Semlitsch HV; Anderer P; Chwatal K Br J Clin Pharmacol; 1994 Feb; 37(2):145-56. PubMed ID: 7910470 [TBL] [Abstract][Full Text] [Related]
5. Early onset anxiolytic efficacy after a single dose of pregabalin: double-blind, placebo- and active-comparator controlled evaluation using a dental anxiety model. Nutt D; Mandel F; Baldinetti F J Psychopharmacol; 2009 Nov; 23(8):867-73. PubMed ID: 18635690 [TBL] [Abstract][Full Text] [Related]
6. A double-blind comparison of alprazolam, diazepam and placebo in the treatment of anxious out-patients. Davison K; Farquharson RG; Khan MC; Majid A Br J Clin Pharmacol; 1985; 19 Suppl 1(Suppl 1):37S-43S. PubMed ID: 2859877 [TBL] [Abstract][Full Text] [Related]
7. A double blind comparison of alprazolam, diazepam and placebo in the treatment of anxious out-patients. Davison K; Farquharson RG; Khan MC; Majid A Psychopharmacology (Berl); 1983; 80(4):308-10. PubMed ID: 6137856 [TBL] [Abstract][Full Text] [Related]
8. Alprazolam in the treatment of generalized anxiety and panic disorders: a double-blind placebo-controlled study. Chouinard G; Annable L; Fontaine R; Solyom L Psychopharmacology (Berl); 1982; 77(3):229-33. PubMed ID: 6126907 [TBL] [Abstract][Full Text] [Related]
9. Validating a human model for anxiety using startle potentiated by cue and context: the effects of alprazolam, pregabalin, and diphenhydramine. Baas JM; Mol N; Kenemans JL; Prinssen EP; Niklson I; Xia-Chen C; Broeyer F; van Gerven J Psychopharmacology (Berl); 2009 Jul; 205(1):73-84. PubMed ID: 19415242 [TBL] [Abstract][Full Text] [Related]
10. Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam. Rickels K; Pollack MH; Feltner DE; Lydiard RB; Zimbroff DL; Bielski RJ; Tobias K; Brock JD; Zornberg GL; Pande AC Arch Gen Psychiatry; 2005 Sep; 62(9):1022-30. PubMed ID: 16143734 [TBL] [Abstract][Full Text] [Related]
11. Abrupt discontinuation of alprazolam and cognitive style in patients with panic disorder: early effects on mood, performance, and vital signs. Uhlenhuth EH; Starcevic V; Qualls C; Antal EJ; Matuzas W; Javaid JI; Barnhill J J Clin Psychopharmacol; 2006 Oct; 26(5):519-23. PubMed ID: 16974197 [TBL] [Abstract][Full Text] [Related]
12. A double-blind evaluation of the safety and efficacy of abecarnil, alprazolam, and placebo in outpatients with generalized anxiety disorder. Abecarnil Work Group. Lydiard RB; Ballenger JC; Rickels K J Clin Psychiatry; 1997; 58 Suppl 11():11-8. PubMed ID: 9363043 [TBL] [Abstract][Full Text] [Related]
13. Anxiolytic effects of vestipitant in a sub-group of healthy volunteers known to be sensitive to CO2 challenge. Poma SZ; Merlo-Pich E; Bettica P; Bani M; Fina P; Ziviani L; Milleri S J Psychopharmacol; 2014 May; 28(5):491-7. PubMed ID: 24108409 [TBL] [Abstract][Full Text] [Related]
14. [Evaluation of the usefulness and effectiveness of anxiolytic therapies in neoplastic diseases]. Ziółko E; Knopik J; Bucior J; Foltyn W; Jastrzebska-Okoń K; Tomczyk A; Kempiński M Pol Merkur Lekarski; 2004 Jun; 16(96):561-4. PubMed ID: 15510897 [TBL] [Abstract][Full Text] [Related]
15. Opipramol for the treatment of generalized anxiety disorder: a placebo-controlled trial including an alprazolam-treated group. Möller HJ; Volz HP; Reimann IW; Stoll KD J Clin Psychopharmacol; 2001 Feb; 21(1):59-65. PubMed ID: 11199949 [TBL] [Abstract][Full Text] [Related]
16. Preoperative alprazolam reduces anxiety in ambulatory surgery patients: a comparison with oral midazolam. De Witte JL; Alegret C; Sessler DI; Cammu G Anesth Analg; 2002 Dec; 95(6):1601-6, table of contents. PubMed ID: 12456424 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of anxiolysis and pain associated with combined peri- and retrobulbar eye block for cataract surgery. Boezaart AP; Berry RA; Laubscher JJ; Nell ML J Clin Anesth; 1998 May; 10(3):204-10. PubMed ID: 9603590 [TBL] [Abstract][Full Text] [Related]
18. Comparison of the efficacy, safety and withdrawal of alpidem and alprazolam in anxious patients. Frattola L; Garreau M; Piolti R; Bassi S; Albizzati MG; Borghi C; Morselli PL Br J Psychiatry; 1994 Jul; 165(1):94-100. PubMed ID: 7802852 [TBL] [Abstract][Full Text] [Related]
19. Double-blind clinical assessment of alprazolam, a new benzodiazepine derivative, in the treatment of moderate to severe anxiety. Greiss KC; Fogari R J Clin Pharmacol; 1980; 20(11):693-9. PubMed ID: 6112245 [TBL] [Abstract][Full Text] [Related]
20. [Efficacy and tolerance of alprazolam and bromazepam in flexible doses. Double-blind study in 119 ambulatory anxious patients]. Ropert R; Bernes J; Dachary JM Encephale; 1987; 13(2):89-95. PubMed ID: 2885173 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]